Travere Therapeutics Reports First Quarter 2023 Financial Results

SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2023 financial results and provided a corporate update.

View Full Press Release

Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)